Brian Gorman insider trades: Opiant Pharmaceuticals (OPNT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brian reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 27, 2023 | OPNT | ↓ Sell | 444 | $20.26 | $9K | Direct | Jan 31, 2023 (4d) |
| Jan 5, 2023 | OPNT | ↓ Sell | 1,313 | $20.20 | $27K | Direct | Jan 5, 2023 (0d) |
| Jul 14, 2022 | OPNT | ↓ Sell | 691 | $11.16 | $8K | Direct | Jul 15, 2022 (1d) |
| Jun 2, 2022 | OPNT | ↓ Sell | 1,148 | $13.52 | $16K | Direct | Jun 6, 2022 (4d) |
| Sep 14, 2021 | OPNT | ↑ Buy | 1,312 | $19.04 | $25K | Direct | Sep 14, 2021 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Brian Gorman's insider trades
Brian Gorman is an insider at Opiant Pharmaceuticals (OPNT). Since Sep 14, 2021, Brian has reported 1 open-market purchase worth $25K and 4 sales worth $59K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OPNT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.